ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden
· Delayed Price · Currency is SEK 19.36
-0.52 (-2.62%)
Apr 30, 2025, 12:51 PM CET
STO:EXPRS2 Revenue
In the year 2024, ExpreS2ion Biotech Holding AB had annual revenue of 7.83M SEK, down -11.07%. ExpreS2ion Biotech Holding AB had revenue of 2.18M in the quarter ending December 31, 2024, a decrease of -4.64%.
Revenue
7.83M
Revenue Growth
-11.07%
P/S Ratio
6.58
Revenue / Employee
391.25K
Employees
20
Market Cap
51.47M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 997.85M |